• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞特异性 Ptpn6 缺失可预防肥胖相关的肝胰岛素抵抗。

Hepatocyte-specific Ptpn6 deletion protects from obesity-linked hepatic insulin resistance.

机构信息

Department of Medicine, Faculty of Medicine, Cardiology Axis of the Institut Universitaire de Cardiologie et de Pneumologie de Québec (Hôpital Laval), Québec, Québec, Canada.

出版信息

Diabetes. 2012 Aug;61(8):1949-58. doi: 10.2337/db11-1502. Epub 2012 Jun 14.

DOI:10.2337/db11-1502
PMID:22698917
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3402325/
Abstract

The protein-tyrosine phosphatase Shp1 negatively regulates insulin action on glucose homeostasis in liver and muscle, but its potential role in obesity-linked insulin resistance has not been examined. To investigate the role of Shp1 in hepatic insulin resistance, we generated hepatocyte-specific Shp1 knockout mice (Ptpn6(H-KO)), which were subjected to extensive metabolic monitoring throughout an 8-week standard chow diet (SD) or high-fat diet (HFD) feeding. We report for the first time that Shp1 expression is upregulated in metabolic tissues of HFD-fed obese mice. When compared with their Shp1-expressing Ptpn6(f/f) littermates, Ptpn6(H-KO) mice exhibited significantly lowered fasting glycemia and heightened hepatic insulin sensitivity. After HFD feeding, Ptpn6(H-KO) mice developed comparable levels of obesity as Ptpn6(f/f) mice, but they were remarkably protected from liver insulin resistance, as revealed by euglycemic clamps and hepatic insulin signaling determinations. Although Ptpn6(H-KO) mice still acquired diet-induced peripheral insulin resistance, they were less hyperinsulinemic during a glucose tolerance test because of reduced insulin secretion. Ptpn6(H-KO) mice also exhibited increased insulin clearance in line with enhanced CC1 tyrosine phosphorylation in liver. These results show that hepatocyte Shp1 plays a critical role in the development of hepatic insulin resistance and represents a novel therapeutic target for obesity-linked diabetes.

摘要

蛋白酪氨酸磷酸酶 Shp1 负向调节肝脏和肌肉中胰岛素对葡萄糖稳态的作用,但它在肥胖相关胰岛素抵抗中的潜在作用尚未被研究。为了研究 Shp1 在肝胰岛素抵抗中的作用,我们生成了肝细胞特异性 Shp1 敲除小鼠(Ptpn6(H-KO)),这些小鼠在 8 周标准饮食(SD)或高脂肪饮食(HFD)喂养期间接受了广泛的代谢监测。我们首次报道 Shp1 在 HFD 喂养肥胖小鼠的代谢组织中表达上调。与表达 Shp1 的 Ptpn6(f/f)同窝仔相比,Ptpn6(H-KO)小鼠表现出明显降低的空腹血糖和增强的肝脏胰岛素敏感性。在 HFD 喂养后,Ptpn6(H-KO)小鼠与 Ptpn6(f/f)小鼠相比发展出相当水平的肥胖,但它们显著免受肝脏胰岛素抵抗的影响,这通过正葡萄糖钳夹和肝胰岛素信号测定揭示。尽管 Ptpn6(H-KO)小鼠仍获得了饮食诱导的外周胰岛素抵抗,但由于胰岛素分泌减少,它们在葡萄糖耐量试验中胰岛素血症程度较低。Ptpn6(H-KO)小鼠还表现出增强的胰岛素清除率,与肝中 CC1 酪氨酸磷酸化增强一致。这些结果表明肝细胞 Shp1 在肝胰岛素抵抗的发展中起着关键作用,代表肥胖相关糖尿病的一个新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb2e/3402325/cea5cad741a8/1949fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb2e/3402325/b79c22c1bb60/1949fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb2e/3402325/5e74ef6718dd/1949fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb2e/3402325/6f07c6b6833c/1949fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb2e/3402325/a8c9c07d3ec6/1949fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb2e/3402325/1ad68875c63b/1949fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb2e/3402325/cea5cad741a8/1949fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb2e/3402325/b79c22c1bb60/1949fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb2e/3402325/5e74ef6718dd/1949fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb2e/3402325/6f07c6b6833c/1949fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb2e/3402325/a8c9c07d3ec6/1949fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb2e/3402325/1ad68875c63b/1949fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb2e/3402325/cea5cad741a8/1949fig6.jpg

相似文献

1
Hepatocyte-specific Ptpn6 deletion protects from obesity-linked hepatic insulin resistance.肝细胞特异性 Ptpn6 缺失可预防肥胖相关的肝胰岛素抵抗。
Diabetes. 2012 Aug;61(8):1949-58. doi: 10.2337/db11-1502. Epub 2012 Jun 14.
2
Hepatocyte-specific Ptpn6 deletion promotes hepatic lipid accretion, but reduces NAFLD in diet-induced obesity: potential role of PPARγ.肝细胞特异性 Ptpn6 缺失促进肝内脂质蓄积,但可减少饮食诱导肥胖的非酒精性脂肪性肝病:PPARγ 的潜在作用。
Hepatology. 2014 May;59(5):1803-15. doi: 10.1002/hep.26957. Epub 2014 Apr 1.
3
β-catenin links hepatic metabolic zonation with lipid metabolism and diet-induced obesity in mice.β-连环蛋白将小鼠肝脏代谢分区与脂质代谢及饮食诱导的肥胖联系起来。
Am J Pathol. 2014 Dec;184(12):3284-98. doi: 10.1016/j.ajpath.2014.08.022. Epub 2014 Oct 7.
4
Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance.肝特异性 Prkn 敲除小鼠更容易发生饮食诱导的肝脂肪变性和胰岛素抵抗。
Mol Metab. 2020 Nov;41:101051. doi: 10.1016/j.molmet.2020.101051. Epub 2020 Jul 10.
5
Hepatic insulin sensitivity is improved in high-fat diet-fed Park2 knockout mice in association with increased hepatic AMPK activation and reduced steatosis.在高脂饮食喂养的Park2基因敲除小鼠中,肝脏胰岛素敏感性得到改善,同时肝脏AMPK激活增加,脂肪变性减少。
Physiol Rep. 2019 Nov;7(21):e14281. doi: 10.14814/phy2.14281.
6
DPP4 deletion in adipose tissue improves hepatic insulin sensitivity in diet-induced obesity.脂肪组织中 DPP4 的缺失可改善饮食诱导肥胖小鼠的肝胰岛素敏感性。
Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E590-E599. doi: 10.1152/ajpendo.00323.2019. Epub 2019 Dec 31.
7
Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice.肝源性大麻素受体 1 通过抑制胰岛素信号和清除作用介导饮食诱导的胰岛素抵抗。
Gastroenterology. 2012 May;142(5):1218-1228.e1. doi: 10.1053/j.gastro.2012.01.032. Epub 2012 Jan 31.
8
Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance.肌肉生长抑制素功能丧失突变可降低肿瘤坏死因子α的产生,并保护肝脏免受肥胖诱导的胰岛素抵抗。
Diabetes. 2009 May;58(5):1133-43. doi: 10.2337/db08-0245. Epub 2009 Feb 10.
9
Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart.激素敏感性脂肪酶基因敲除小鼠的肝脏胰岛素敏感性增强,并且在短期饮食诱导的情况下,其骨骼肌和心脏可免受胰岛素抵抗的影响。
Am J Physiol Endocrinol Metab. 2005 Jul;289(1):E30-9. doi: 10.1152/ajpendo.00251.2004. Epub 2005 Feb 8.
10
Partial leptin deficiency confers resistance to diet-induced obesity in mice.部分瘦素缺乏症使小鼠对饮食诱导的肥胖具有抵抗力。
Mol Metab. 2020 Jul;37:100995. doi: 10.1016/j.molmet.2020.100995. Epub 2020 Apr 11.

引用本文的文献

1
IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease.IFNγ-IL12 轴调节代谢相关脂肪性肝病中细胞间的串扰。
Nat Commun. 2024 Jun 29;15(1):5506. doi: 10.1038/s41467-024-49633-y.
2
Regulation of PPARγ2 Stability and Activity by SHP-1.SHP-1 对 PPARγ2 稳定性和活性的调节。
Mol Cell Biol. 2024;44(7):261-272. doi: 10.1080/10985549.2024.2354959. Epub 2024 Jun 3.
3
Vanadium Complexes with Thioanilide Derivatives of Amino Acids: Inhibition of Human Phosphatases and Specificity in Various Cell Models of Metabolic Disturbances.

本文引用的文献

1
Substrate specificity of protein tyrosine phosphatases 1B, RPTPα, SHP-1, and SHP-2.蛋白酪氨酸磷酸酶 1B、RPTPα、SHP-1 和 SHP-2 的底物特异性。
Biochemistry. 2011 Mar 29;50(12):2339-56. doi: 10.1021/bi1014453. Epub 2011 Feb 18.
2
Compartmentalized CDK2 is connected with SHP-1 and β-catenin and regulates insulin internalization.细胞分区的 CDK2 与 SHP-1 和 β-连环蛋白相连,并调节胰岛素内吞。
Cell Signal. 2011 May;23(5):911-9. doi: 10.1016/j.cellsig.2011.01.019. Epub 2011 Jan 22.
3
Prep1 controls insulin glucoregulatory function in liver by transcriptional targeting of SHP1 tyrosine phosphatase.
含氨基酸硫代苯胺衍生物的钒配合物:对人磷酸酶的抑制作用及在各种代谢紊乱细胞模型中的特异性
Pharmaceuticals (Basel). 2024 Feb 9;17(2):229. doi: 10.3390/ph17020229.
4
Dual PTP1B/TC-PTP Inhibitors: Biological Evaluation of 3-(Hydroxymethyl)cinnoline-4()-Ones.双 PTP1B/TC-PTP 抑制剂:3-(羟甲基)喹啉-4(1H)-酮类化合物的生物学评价。
Int J Mol Sci. 2023 Feb 24;24(5):4498. doi: 10.3390/ijms24054498.
5
A novel combination of sitagliptin and melatonin ameliorates T2D manifestations: studies on experimental diabetic models.西格列汀与褪黑素的新组合可改善 T2D 表现:在实验性糖尿病模型上的研究。
J Endocrinol Invest. 2023 Aug;46(8):1597-1612. doi: 10.1007/s40618-023-02014-6. Epub 2023 Jan 24.
6
Oxidative stress in obesity-associated hepatocellular carcinoma: sources, signaling and therapeutic challenges.肥胖相关肝细胞癌中的氧化应激:来源、信号转导和治疗挑战。
Oncogene. 2021 Aug;40(33):5155-5167. doi: 10.1038/s41388-021-01950-y. Epub 2021 Jul 21.
7
Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1-mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma.根皮素通过抑制 SHP-1 介导的 STAT3 和 Akt/VEGFR2 通路来抑制 STAT3 活性,从而克服索拉非尼耐药,靶向肝癌。
Cell Commun Signal. 2019 Oct 16;17(1):127. doi: 10.1186/s12964-019-0430-7.
8
Targeted SHP-1 Silencing Modulates the Macrophage Phenotype, Leading to Metabolic Improvement in Dietary Obese Mice.靶向沉默SHP-1可调节巨噬细胞表型,改善饮食诱导肥胖小鼠的代谢状况。
Mol Ther Nucleic Acids. 2019 Jun 7;16:626-636. doi: 10.1016/j.omtn.2019.04.020. Epub 2019 Apr 30.
9
The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1.HNF1α 调控的长链非编码 RNA HNF1A-AS1 通过增强 SHP-1 的磷酸酶活性逆转肝癌的恶性表型。
Mol Cancer. 2018 Feb 21;17(1):63. doi: 10.1186/s12943-018-0813-1.
10
Hepatocyte SHP-1 is a Critical Modulator of Inflammation During Endotoxemia.肝细胞 SHP-1 是内毒素血症期间炎症的关键调节因子。
Sci Rep. 2017 May 22;7(1):2218. doi: 10.1038/s41598-017-02512-7.
Prep1 通过靶向作用于 SHP1 酪氨酸磷酸酶来调控肝脏的胰岛素糖调节功能。
Diabetes. 2011 Jan;60(1):138-47. doi: 10.2337/db10-0860. Epub 2010 Sep 23.
4
Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action.肝实质细胞中的白细胞介素-6 信号抑制肝内炎症并改善全身胰岛素作用。
Cell Metab. 2010 Sep 8;12(3):237-49. doi: 10.1016/j.cmet.2010.06.011.
5
Inducible nitric oxide synthase induction underlies lipid-induced hepatic insulin resistance in mice: potential role of tyrosine nitration of insulin signaling proteins.诱导型一氧化氮合酶诱导是小鼠脂诱导性肝胰岛素抵抗的基础:胰岛素信号蛋白酪氨酸硝化的潜在作用。
Diabetes. 2010 Apr;59(4):861-71. doi: 10.2337/db09-1238. Epub 2010 Jan 26.
6
Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity.库普弗细胞通过白细胞介素-1β依赖性抑制过氧化物酶体增殖物激活受体α活性促进肝脂肪变性。
Hepatology. 2010 Feb;51(2):511-22. doi: 10.1002/hep.23337.
7
Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1.由于肝特异性敲除 CEACAM1 导致胰岛素清除受损的小鼠破骨细胞生成减少和骨量增加。
Bone. 2010 Apr;46(4):1138-45. doi: 10.1016/j.bone.2009.12.020. Epub 2010 Jan 4.
8
Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance.耗竭肝枯否细胞可预防饮食诱导的肝脂肪变性和胰岛素抵抗的发生。
Diabetes. 2010 Feb;59(2):347-57. doi: 10.2337/db09-0016. Epub 2009 Nov 23.
9
Kupffer cell activation is a causal factor for hepatic insulin resistance.枯否细胞激活是肝胰岛素抵抗的一个因果因素。
Am J Physiol Gastrointest Liver Physiol. 2010 Jan;298(1):G107-16. doi: 10.1152/ajpgi.00391.2009. Epub 2009 Oct 29.
10
Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling.饮食诱导肥胖过程中枯否细胞的缺失与肝脏脂肪变性增加、信号转导和转录激活因子3(STAT3)信号增强以及胰岛素信号进一步减弱有关。
Biochim Biophys Acta. 2009 Nov;1792(11):1062-72. doi: 10.1016/j.bbadis.2009.08.007. Epub 2009 Aug 20.